Terms: = Liver cancer AND ERCC2, TTD, 2068, ENSG00000104884, COFS2, P18074, MGC102762, XPD, MGC126219, MGC126218, EM9 AND Staging
3 results:
1. FOLFIRINOX or gemcitabine/nab-paclitaxel in advanced pancreatic adenocarcinoma: A novel validated prognostic score to facilitate treatment decision-making in real-world.
Marschner N; Hegewisch-Becker S; Reiser M; von der Heyde E; Bertram M; Hollerbach SH; Kreher S; Wolf T; Binninger A; Chiabudini M; Kaiser-Osterhues A; Jänicke M;
Int J Cancer; 2023 Feb; 152(3):458-469. PubMed ID: 36053905
[TBL] [Abstract] [Full Text] [Related]
2. Identification of distinct phenotypes of locally advanced pancreatic adenocarcinoma.
Teo M; Crotty GF; O'Súilleabháin C; Ridgway PF; Conlon KC; Power DG; McDermott RS
J Gastrointest Cancer; 2013 Mar; 44(1):73-8. PubMed ID: 22829058
[TBL] [Abstract] [Full Text] [Related]
3. Association of APE1 and hOGG1 polymorphisms with colorectal cancer risk in a Turkish population.
Canbay E; Cakmakoglu B; Zeybek U; Sozen S; Cacina C; Gulluoglu M; Balik E; Bulut T; Yamaner S; Bugra D
Curr Med Res Opin; 2011 Jul; 27(7):1295-302. PubMed ID: 21561390
[TBL] [Abstract] [Full Text] [Related]
